Richman Eric I's Form 4 filing
Gain Therapeutics, Inc. (GANX) · filed Jul 1, 2024
- Accession no.
- 0001493152-24-025831
- Filed
- Jul 1, 2024
- Trade date
- Jul 1, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $20.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richman Eric ICIK 0001313876 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $1.23 | +$6,150 | 277,629 | Direct | |
| Jul 1, 2024 | Common Stock | PPurchaseAcquired | +12,000 | $1.21 | +$14,520 | 289,629 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.